1. A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast Cancer. Issue 4 (April 2022) Authors: Lerner, A.; Keshwani, K.; Okines, A.; Sanderson, B.; Board, R.E.; Flynn, M.; Sharkey, E.; Konstantis, A.; Roylance, R.; Hanna, D.; King, J.; Murphy, R.; Rehman, F.; Guppy, A.E.; Westbury, C.; Takeuchi, E.; Spurrell, E.; Jayaweera, H.K.; Raja, F. Journal: Clinical oncology Issue: Volume 34:Issue 4(2022) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Single UK Centre's Real-world Experience with Cabazitaxel for Metastatic Castrate Resistant Prostate Cancer. Issue 3 (March 2022) Authors: Oong, Z.C.; Sanderson, B.; Warren, S.; Parikh, O.; Charnley, N.; Haston, J.; Birtle, A. Journal: Clinical oncology Issue: Volume 34:Issue 3(2022) Page Start: e146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bring on BCON! The Unmet Need of Bladder Cancer Patients Unsuitable for Chemoradiation Treated with Radical Radiotherapy Alone. Issue 2 (February 2023) Authors: Iftikhar, J.; Egan, H.; Sanderson, B.; Mohamed, I.; Birtle, A. Journal: Clinical oncology Issue: Volume 35:Issue 2(2023) Page Start: e238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Is Universal Patient Access to Fulvestrant in Hormone Receptor-positive Advanced Breast Cancer Justified? A UK Retrospective Multicentre Study. Issue 8 (August 2020) Authors: Lerner, A.; Keshwani, K.; Sanderson, B.; Board, R.E.; Flynn, M.; Sharkey, E.; Okines, A.; Konstantis, A.; Roylance, R.; Hanna, D.; King, J.; Murphy, R.; Rehman, F.; Guppy, A.; Westbury, C.; Takeuchi, E.; Spurrell, E.; Raja, F. Journal: Clinical oncology Issue: Volume 32:Issue 8(2020) Page Start: e167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Optimum nutritional support in adults receiving veno-venous extracorporeal membrane oxygenation is possible but underfeeding is common, especially in those with more severe organ dysfunction. (December 2017) Authors: Kaakinen, L.; Smith, E.; Elliott Hammond, C.; Sanderson, B.; Ong, D.; Daly, K.; Barrett, N.; Whelan, K.; Bear, D. Journal: Clinical nutrition ESPEN Issue: Volume 22(2017) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-0788: Predicted patient demand for MRI Linac. (April 2016) Authors: Sanderson, B.; McWilliam, A.; Faivre-Finn, C.; Choudhury, A.; Mee, T. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-1518 Effect of bladder filling protocols on bladder volume variation in the age of adaptive radiotherapy. (August 2021) Authors: Sanderson, B.; Joseph, N.; Elumalai, T.; Cree, A.; van Herk, M.; Hoskin, P.; McWilliam, A.; Song, Y.P.; Choudhury, A. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Reframing Future Risks of Extreme Heat in the United States. Issue 9 (26th September 2018) Authors: Wobus, C.; Zarakas, C.; Malek, P.; Sanderson, B.; Crimmins, A.; Kolian, M.; Sarofim, M.; Weaver, C. P. Journal: Earth's future Issue: Volume 6:Issue 9(2018) Page Start: 1323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Using Real-world Data to Define a Validated Nomogram for Advanced Bladder Cancer Patients Who Respond to Immunotherapy. Issue 10 (October 2022) Authors: Elumalai, T.; Croxford, W.; Buijtenhuijs, B.; Conroy, R.; Sanderson, B.; Enting, D.; Aversa, C.; Doss, G.; Das, A.; Vasudev, N.S.; Kitetere, E.; Tolan, S.; Law, A.; Hoskin, P.; Mistry, H.; Choudhury, A. Journal: Clinical oncology Issue: Volume 34:Issue 10(2022) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗